Two outstanding Kenyan marathoners have been suspended from competitors on doping fees, based on a report by Capital Sports activities. The Athletics Integrity Unit (AIU) has banned Paul Lonyangata for 19 months to be used of the drug Furosemide, and Edward Kiprop Kibet has been banned for 3 years for nandrolone.
🏆 CLASSEMENT OFFICIEL 🏆
Hommes :
1⃣ – Paul Lonyangata 2:06:10
2⃣ – Stephen Chebogout 2:06:56
3⃣ – Solomon Yego 2:07:13#ParisMarathon pic.twitter.com/11x1Dapyri— Schneider Electrical Marathon de Paris (@parismarathon) April 9, 2017
Lonyangata gained the Paris Marathon in 2017 and 2018, and was the third-place finisher in 2019. One week after the 2019 race, he admitted to utilizing the banned substance Furosemide, after it was present in an out-of-competition pattern in September. Furosemide is a coronary heart medicine, however it’s on the World Anti-Doping Company’s (WADA) listing of prohibited substances as a result of it might probably masks the presence of performance-enhancing medication.
Lonyangata rose to fame in 2017, not solely as a result of he gained the Paris Marathon, however as a result of his spouse, Purity Rionoripo, gained the ladies’s race on the identical day.
Lonyangata can be banned from competitors till Could 25, 2023. His fellow countryman, Kibet, can be banned from all competitors till February 2025, after testing constructive for nandrolone, the identical substance present in Shelby Houlihan’s pattern final yr, for which she was given a four-year ban.
